Herzog, Thomas J.

Trabectedin plus pegylated liposomal doxorubicin in recurrent ovarian cancer

Monk, B. J., Herzog, T. J., Kaye, S. B., Krasner, C. N., Vermorken, J. B., Muggia, F. M., Pujade-Lauraine, E., Lisyanskaya, A. S., Makhson, A. N., Rolski, J., et al. (2010) · Journal of Clinical Oncology

Ovarian cancer diagnosis and treatmentPARP inhibition in cancer therapy

Cited by 395

Endometriosis: where are we and where are we going?

Greene, A. D., Lang, S. A., Kendziorski, J. A., Sroga-Rios, J. M., Herzog, T. J., & Burns, K. A. (2016) · Reproduction

Endometriosis Research and TreatmentEctopic Pregnancy Diagnosis and Management

Cited by 187

Predictors of massive blood loss in women with placenta accreta

Wright, J. D., Pri-Paz, S., Herzog, T. J., Shah, M., Bonanno, C., Lewin, S. N., Simpson, L. L., Gaddipati, S., Sun, X., D'Alton, M. E., et al. (2011) · American Journal of Obstetrics and Gynecology

Maternal and fetal healthcareBlood transfusion and management

Cited by 150

The impact of cervical cancer on quality of life—The components and means for management

Herzog, T. J., & Wright, J. D. (2007) · Gynecologic Oncology

Women's cancer prevention and managementCancer survivorship and care

Cited by 119

Practice patterns and knowledge of obstetricians and gynecologists regarding placenta accreta

Wright, J. D., Silver, R. M., Bonanno, C., Gaddipati, S., Lu, Y.-S., Simpson, L. L., Herzog, T. J., Schulkin, J., & D’Alton, M. E. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine

Maternal and fetal healthcareBlood transfusion and management

Cited by 67